Edition:
United States

Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

29.70USD
9 Dec 2016
Change (% chg)

$-1.78 (-5.65%)
Prev Close
$31.48
Open
$31.74
Day's High
$32.05
Day's Low
$29.39
Volume
703,065
Avg. Vol
325,956
52-wk High
$50.86
52-wk Low
$22.67

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.56 December 9 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 5 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.70 1.70 1.70

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 8 3.56 7.60 1.20 12.82
Quarter Ending Mar-17 3 3.58 4.14 3.25 --
Year Ending Dec-16 9 27.99 32.00 26.00 26.28
Year Ending Dec-17 9 37.45 151.80 9.00 68.62
Earnings (per share)
Quarter Ending Dec-16 10 -0.56 -0.41 -0.68 -0.39
Quarter Ending Mar-17 3 -0.58 -0.56 -0.60 --
Year Ending Dec-16 10 -1.58 -1.50 -1.70 -1.82
Year Ending Dec-17 10 -1.84 0.80 -2.82 -1.30

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 4.07 3.01 1.07 26.22
Quarter Ending Jun-16 3.77 3.19 0.58 15.34
Quarter Ending Mar-16 9.49 18.20 8.71 91.77
Quarter Ending Dec-15 15.69 3.80 11.89 75.76
Quarter Ending Sep-15 4.38 4.16 0.22 5.13
Earnings (per share)
Quarter Ending Sep-16 -0.53 -0.55 0.02 -3.02
Quarter Ending Jun-16 -0.50 -0.59 0.09 -17.95
Quarter Ending Mar-16 -0.26 0.13 0.39 -150.13
Quarter Ending Dec-15 -0.09 -0.81 0.72 -779.48
Quarter Ending Sep-15 -0.46 -0.36 0.10 -21.50

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 3.56 3.56 3.63 3.79 12.82
Quarter Ending Mar-17 3.58 3.58 3.69 4.19 --
Year Ending Dec-16 27.99 27.99 28.12 28.19 26.28
Year Ending Dec-17 37.45 37.45 39.18 40.00 68.62
Earnings (per share)
Quarter Ending Dec-16 -0.56 -0.56 -0.56 -0.56 -0.39
Quarter Ending Mar-17 -0.58 -0.58 -0.57 -0.57 --
Year Ending Dec-16 -1.58 -1.58 -1.58 -1.59 -1.82
Year Ending Dec-17 -1.84 -1.84 -1.77 -1.76 -1.30

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 0 1
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 0 2
Year Ending Dec-17 0 0 0 1
Earnings
Quarter Ending Dec-16 0 0 1 0
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 1